A critical advance in cancer research is arising with the use of mini-antibodies to re-engage mutated p53. This essential tumor inhibitor protein is frequently disabled in many forms of cancer, causing uncontrolled https://bookmarkja.com/story24841753/mini-antibodies-restore-p53-the-new-hope-for-tumor-treatment